Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein

被引:189
作者
Kitabayashi, I
Aikawa, Y
Nguyen, LA
Yokoyama, A
Ohki, M
机构
[1] Natl Canc Ctr, Res Inst, Canc Gen Div, Chuo Ku, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Chromatin Funct Leukemogenesis Project, Chuo Ku, Tokyo 1040045, Japan
关键词
AML1; histone acetylation; leukemia; MOZ;
D O I
10.1093/emboj/20.24.7184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The AML1-CBF beta transcription factor complex is the most frequent target of specific chromosome translocations in human leukemia. The MOZ gene, which encodes a histone acetyltransferase (HAT), is also involved in some leukemia-associated translocations. We report here that MOZ is part of the AML1 complex and strongly stimulates AML1-mediated transcription. The stimulation of AML1-mediated transcription is independent of the inherent HAT activity of MOZ. Rather, a potent transactivation domain within MOZ appears to be essential for stimulation of AML1-mediated transcription. MOZ, as well as CBP and MOZ-CBP, can acetylate AML1 in vitro. The amount of AML1-MOZ complex increases during the differentiation of M1 myeloid cells into monocytes/macrophages, suggesting that the AML1-MOZ complex might play a role in cell differentiation. On the other hand, the MOZ-CBP fusion protein, which is created by the t(8;16) translocation associated with acute monocytic leukemia, inhibits AML1-mediated transcription and differentiation of M1 cells. These results suggest that MOZ-CBP might induce leukemia by antagonizing the function of the AML1 complex.
引用
收藏
页码:7184 / 7196
页数:13
相关论文
共 48 条
[1]   The translocation t(8;l6)(p11, p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB binding protein [J].
Borrow, J ;
Stanton, VP ;
Andresen, JM ;
Becher, R ;
Behm, FG ;
Chaganti, RSK ;
Civin, CI ;
Disteche, C ;
Dube, I ;
Frischauf, AM ;
Horsman, D ;
Mitelman, F ;
Volinia, S ;
Watmore, AE ;
Housman, DE .
NATURE GENETICS, 1996, 14 (01) :33-41
[2]   A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia [J].
Carapeti, M ;
Aguiar, RCT ;
Goldman, JM ;
Cross, NCP .
BLOOD, 1998, 91 (09) :3127-3133
[3]  
Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO
[4]  
2-2
[5]   The monocytic leukemia zinc finger protein MOZ is is histone acetyltransferase [J].
Champagne, N ;
Pelletier, N ;
Yang, XJ .
ONCOGENE, 2001, 20 (03) :404-409
[6]   Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase [J].
Chen, HW ;
Lin, RJ ;
Xie, W ;
Wilpitz, D ;
Evans, RM .
CELL, 1999, 98 (05) :675-686
[7]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[8]   Structure and ligand of a histone acetyltransferase bromodomain [J].
Dhalluin, C ;
Carlson, JE ;
Zeng, L ;
He, C ;
Aggarwal, AK ;
Zhou, MM .
NATURE, 1999, 399 (6735) :491-496
[9]   Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO [J].
Gelmetti, V ;
Zhang, JS ;
Fanelli, M ;
Minucci, S ;
Pelicci, PG ;
Lazar, MA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7185-7191
[10]   Histone acetylation in chromatin structure and transcription [J].
Grunstein, M .
NATURE, 1997, 389 (6649) :349-352